GlassScriptPhysician profile
Maliha Saeed
NPI 1861834145
$1,885.15
in general payments reported to CMS, 2019-2025
18 companies · $566 in 2025
The $566 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $154 · 2021: $64.56 · 2022: $220 · 2023: $338 · 2024: $259 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,163.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $496.01 | 2019-2023 | Acuvue |
| Mallinckrodt Hospital Products INC. | $267.98 | 2020-2025 | Acthar |
| Alcon Vision LLC | $242.55 | 2019-2025 | Clareon, Clareon Panoptix Pro |
| Sun Pharmaceutical Industries INC. | $150.79 | 2023-2025 | Cequa, Bromsite, Xelpros |
| Sight Sciences, INC. | $140.85 | 2022-2025 | Omni Surgical System, Tearcare System |
| Tarsus Pharmaceuticals, INC. | $137.41 | 2024-2025 | Xdemvy |
| Abbvie INC. | $108.31 | 2022-2023 | Durysta |
| Harrow Eye, LLC | $59.31 | 2025 | Vevye |
| Biotissue Holdings INC. | $49.45 | 2024-2025 | |
| Glaukos Corporation | $44.46 | 2025 | Idosetr |
| Bausch & Lomb Americas INC. | $42.96 | 2023-2025 | Xiidra, Miebo |
| Rxsight INC | $38.82 | 2022-2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Mallinckrodt Enterprises LLC | $21.96 | 2019 | |
| Kala Pharmaceuticals, INC. | $21.87 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.75 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $17.11 | 2019 | |
| Oyster Point Pharma, INC. | $14.14 | 2023 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $12.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maliha Saeed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.